TOR Complexes and the Maintenance of Cellular Homeostasis

Trends in Cell Biology

Volumn 26, Issue 2, 2016, Pages 148-159

  Eltschinger, Sandra ^a,b   Loewith, Robbie ^a,b,c  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b Institute of Genetics and Genomics of Geneva (iGE3)   (Switzerland)

^c Swiss National Centre for Competence in Research Programme Chemical Biology   (Switzerland)

Author keywords

Eisosome; Growth; Homeostasis; Membrane tension; Osmotic control; Sphingolipid; Target Of Rapamycin (TOR)

Indexed keywords

CERAMIDE; GLYCEROL; LIPID; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; RAPAMYCIN; SPHINGOLIPID; TARGET OF RAPAMYCIN COMPLEX; TARGET OF RAPAMYCIN COMPLEX 1; TARGET OF RAPAMYCIN COMPLEX 2; TARGET OF RAPAMYCIN KINASE; UNCLASSIFIED DRUG; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; TOR COMPLEX 2;

ABIOTIC STRESS; BIOSYNTHESIS; BIOTIC STRESS; CELL GROWTH; CELL MEMBRANE; CELL METABOLISM; CELL SURFACE; CELL TURGOR; CELL VACUOLE; CELL VOLUME; EXTRACELLULAR MATRIX; FEEDBACK SYSTEM; GLYCOLYSIS; HOMEOSTASIS; LIPOGENESIS; MEDIATOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; REVIEW; CELL FUNCTION; CELL SIZE; GENETICS; HUMAN; LIPID METABOLISM; PHYSIOLOGY; YEAST;

CELL PHYSIOLOGICAL PHENOMENA; CELL SIZE; HOMEOSTASIS; HUMANS; LIPID METABOLISM; MULTIPROTEIN COMPLEXES; TOR SERINE-THREONINE KINASES; YEASTS;

EID: 84957587533     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2015.10.003     Document Type: Review

References (100)

1. Shertz C.A., et al. Conservation, duplication, and loss of the Tor signaling pathway in the fungal kingdom. BMC Genomics 2010, 11:510.
2. Heitman J., et al. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 1991, 253:905-909.
3. Marcet-Houben M., Gabaldon T. Beyond the whole-genome duplication: phylogenetic evidence for an ancient interspecies hybridization in the Baker's yeast lineage. PLoS Biol. 2015, 13:e1002220.
4. Loewith R., et al. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 2002, 10:457-468.
5. Hara K., et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 2002, 110:177-189.
6. Jacinto E., et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 2004, 6:1122-1128.
7. Kim D.H., et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002, 110:163-175.
8. Sarbassov D.D., et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 2004, 14:1296-1302.
9. Choi J., et al. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP. Science 1996, 273:239-242.
10. Liang J., et al. Refined structure of the FKBP12-rapamycin-FRB ternary complex at 2.2 A resolution. Acta Crystallogr. D Biol. Crystallogr. 1999, 55:736-744.
11. Yip C.K., et al. Structure of the human mTOR complex I and its implications for rapamycin inhibition. Mol. Cell 2010, 38:768-774.
12. Yang H., et al. mTOR kinase structure, mechanism and regulation. Nature 2013, 497:217-223.
13. Kang S.A., et al. mTORC1 phosphorylation sites encode their sensitivity to starvation and rapamycin. Science 2013, 341:1236566.
14. Hassan B., et al. Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors. Oncotarget 2014, 5:8544-8557.
15. Cirstea D., et al. Delineating the mTOR kinase pathway using a dual TORC1/2 inhibitor AZD8055, in multiple myeloma. Mol. Cancer Ther. 2014, 13:2489-2500.
16. Albert V., Hall M.N. mTOR signaling in cellular and organismal energetics. Curr. Opin. Cell Biol. 2015, 33:55-66.
17. Laplante M., Sabatini D.M. mTOR signaling in growth control and disease. Cell 2012, 149:274-293.
18. Gaubitz C., et al. Molecular basis of the rapamycin insensitivity of target of rapamycin complex 2. Mol. Cell 2015, 58:977-988.
19. Urban J., et al. Sch9 is a major target of TORC1 in Saccharomyces cerevisiae. Mol. Cell 2007, 26:663-674.
20. Berchtold D., Walther T.C. TORC2 plasma membrane localization is essential for cell viability and restricted to a distinct domain. Mol. Biol. Cell 2009, 20:1565-1575.
21. Binda M., et al. The Vam6 GEF controls TORC1 by activating the EGO complex. Mol. Cell 2009, 35:563-573.
22. Sturgill T.W., et al. TOR1 and TOR2 have distinct locations in live cells. Eukaryot. Cell 2008, 7:1819-1830.
23. Panchaud N., et al. SEACing the GAP that nEGOCiates TORC1 activation: evolutionary conservation of Rag GTPase regulation. Cell Cycle 2013, 12:2948-2952.
24. Jewell J.L., et al. Amino acid signalling upstream of mTOR. Nat. Rev. Mol. Cell Biol. 2013, 14:133-139.
25. Kim E., et al. Regulation of TORC1 by Rag GTPases in nutrient response. Nat. Cell Biol. 2008, 10:935-945.
26. Sancak Y., et al. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010, 141:290-303.
27. Sancak Y., et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 2008, 320:1496-1501.
28. Schmelzle T., Hall M.N. TOR, a central controller of cell growth. Cell 2000, 103:253-262.
29. Loewith R., Hall M.N. Target of rapamycin (TOR) in nutrient signaling and growth control. Genetics 2011, 189:1177-1201.
30. Huber A., et al. Characterization of the rapamycin-sensitive phosphoproteome reveals that Sch9 is a central coordinator of protein synthesis. Genes Dev. 2009, 23:1929-1943.
31. Hinnebusch A.G. Translational regulation of GCN4 and the general amino acid control of yeast. Annu. Rev. Microbiol. 2005, 59:407-450.
32. Lempiainen H., Shore D. Growth control and ribosome biogenesis. Curr. Opin. Cell Biol. 2009, 21:855-863.
33. Lempiainen H., et al. Sfp1 interaction with TORC1 and Mrs6 reveals feedback regulation on TOR signaling. Mol. Cell 2009, 33:704-716.
34. Khaleghpour K., et al. Translational homeostasis: eukaryotic translation initiation factor 4E control of 4E-binding protein 1 and p70 S6 kinase activities. Mol. Cell. Biol. 1999, 19:4302-4310.
35. Russell R.C., et al. Autophagy regulation by nutrient signaling. Cell Res. 2014, 24:42-57.
36. Feng Y., et al. How to control self-digestion: transcriptional, post-transcriptional, and post-translational regulation of autophagy. Trends Cell Biol. 2015, 25:354-363.
37. Yu L., et al. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 2010, 465:942-946.
38. Shin C.S., Huh W.K. Bidirectional regulation between TORC1 and autophagy in Saccharomyces cerevisiae. Autophagy 2011, 7:854-862.
39. Yang Z., Klionsky D.J. Permeases recycle amino acids resulting from autophagy. Autophagy 2007, 3:149-150.
40. Roczniak-Ferguson A., et al. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci. Signal. 2012, 5:ra42.
41. Settembre C., et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 2012, 31:1095-1108.
42. Andersen D.S., et al. Coordination of organ growth: principles and outstanding questions from the world of insects. Trends Cell Biol. 2013, 23:336-344.
43. Helliwell S.B., et al. TOR2 is part of two related signaling pathways coordinating cell growth in Saccharomyces cerevisiae. Genetics 1998, 148:99-112.
44. Kamada Y., et al. Tor2 directly phosphorylates the AGC kinase Ypk2 to regulate actin polarization. Mol. Cell. Biol. 2005, 25:7239-7248.
45. Schmidt A., et al. TOR2 is required for organization of the actin cytoskeleton in yeast. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:13780-13785.
46. deHart A.K., et al. The conserved Pkh-Ypk kinase cascade is required for endocytosis in yeast. J. Cell Biol. 2002, 156:241-248.
47. deHart A.K., et al. Receptor internalization in yeast requires the Tor2-Rho1 signaling pathway. Mol. Biol. Cell 2003, 14:4676-4684.
48. Mulet J.M., et al. Mutual antagonism of target of rapamycin and calcineurin signaling. J. Biol. Chem. 2006, 281:33000-33007.
49. Niles B.J., et al. Plasma membrane recruitment and activation of the AGC kinase Ypk1 is mediated by target of rapamycin complex 2 (TORC2) and its effector proteins Slm1 and Slm2. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:1536-1541.
50. Casamayor A., et al. Functional counterparts of mammalian protein kinases PDK1 and SGK in budding yeast. Curr. Biol. 1999, 9:186-197.
51. Pearce L.R., et al. The nuts and bolts of AGC protein kinases. Nat. Rev. Mol. Cell Biol. 2010, 11:9-22.
52. Klug L., Daum G. Yeast lipid metabolism at a glance. FEMS Yeast Res. 2014, 14:369-388.
53. Dickson R.C. Thematic review series: sphingolipids. New insights into sphingolipid metabolism and function in budding yeast. J. Lipid Res. 2008, 49:909-921.
54. Spiegel S., Milstien S. Sphingosine-1-phosphate: signaling inside and out. FEBS Lett. 2000, 476:55-57.
55. Dickson R.C., et al. Sphingolipids are potential heat stress signals in Saccharomyces. J. Biol. Chem. 1997, 272:30196-30200.
56. +-sensitive csg2Delta mutant. J. Biol. Chem. 1998, 273:30688-30694.
57. Sun Y., et al. Sli2 (Ypk1), a homologue of mammalian protein kinase SGK, is a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. Mol. Cell. Biol. 2000, 20:4411-4419.
58. Breslow D.K., et al. Orm family proteins mediate sphingolipid homeostasis. Nature 2010, 463:1048-1053.
59. Berchtold D., et al. Plasma membrane stress induces relocalization of Slm proteins and activation of TORC2 to promote sphingolipid synthesis. Nat. Cell Biol. 2012, 14:542-547.
60. Roelants F.M., et al. Protein kinase Ypk1 phosphorylates regulatory proteins Orm1 and Orm2 to control sphingolipid homeostasis in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:19222-19227.
61. Sun Y., et al. Orm protein phosphoregulation mediates transient sphingolipid biosynthesis response to heat stress via the Pkh-Ypk and Cdc55-PP2A pathways. Mol. Biol. Cell 2012, 23:2388-2398.
62. Rispal D., et al. Target of rapamycin complex 2 regulates actin polarization and endocytosis via multiple pathways. J. Biol. Chem. 2015, 290:14963-14978.
63. Aronova S., et al. Regulation of ceramide biosynthesis by TOR complex 2. Cell Metab. 2008, 7:148-158.
64. Muir A., et al. TORC2-dependent protein kinase Ypk1 phosphorylates ceramide synthase to stimulate synthesis of complex sphingolipids. Elife 2014, 3:03779.
65. Zimmermann C., et al. TORC1 inhibits GSK3-mediated Elo2 phosphorylation to regulate very long chain fatty acid synthesis and autophagy. Cell Rep. 2013, 5:1036-1046.
66. Fresques T., et al. Regulation of ceramide synthase by casein kinase 2-dependent phosphorylation in Saccharomyces cerevisiae. J. Biol. Chem. 2015, 290:1395-1403.
67. Liu M., et al. Regulation of sphingolipid synthesis through Orm1 and Orm2 in yeast. J. Cell Sci. 2012, 125:2428-2435.
68. Shimobayashi M., et al. TORC1-regulated protein kinase Npr1 phosphorylates Orm to stimulate complex sphingolipid synthesis. Mol. Biol. Cell 2013, 24:870-881.
69. Roelants F.M., et al. A protein kinase network regulates the function of aminophospholipid flippases. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:34-39.
70. Nakano K., et al. Protein kinases Fpk1p and Fpk2p are novel regulators of phospholipid asymmetry. Mol. Biol. Cell 2008, 19:1783-1797.
71. Sebastian T.T., et al. Phospholipid flippases: building asymmetric membranes and transport vesicles. Biochim. Biophys. Acta 2012, 1821:1068-1077.
72. Das A., et al. Flippase-mediated phospholipid asymmetry promotes fast Cdc42 recycling in dynamic maintenance of cell polarity. Nat. Cell Biol. 2012, 14:304-310.
73. Niles B.J., Powers T. TOR complex 2-Ypk1 signaling regulates actin polarization via reactive oxygen species. Mol. Biol. Cell 2014, 25:3962-3972.
74. Roelants F.M., et al. Protein kinase Gin4 negatively regulates flippase function and controls plasma membrane asymmetry. J. Cell Biol. 2015, 208:299-311.
75. Lee Y.J., et al. Reciprocal phosphorylation of yeast glycerol-3-phosphate dehydrogenases in adaptation to distinct types of stress. Mol. Cell. Biol. 2012, 32:4705-4717.
76. Muir A., et al. Down-regulation of TORC2-Ypk1 signaling promotes MAPK-independent survival under hyperosmotic stress. Elife 2015, 4:09336.
77. Fadri M., et al. The pleckstrin homology domain proteins Slm1 and Slm2 are required for actin cytoskeleton organization in yeast and bind phosphatidylinositol-4,5-bisphosphate and TORC2. Mol. Biol. Cell 2005, 16:1883-1900.
78. Audhya A., et al. Genome-wide lethality screen identifies new PI4,5P2 effectors that regulate the actin cytoskeleton. EMBO J. 2004, 23:3747-3757.
79. Sinha B., et al. Cells respond to mechanical stress by rapid disassembly of caveolae. Cell 2011, 144:402-413.
80. Sedding D.G., et al. Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo. Circ. Res. 2005, 96:635-642.
81. Humphrey S.J., et al. Dynamic adipocyte phosphoproteome reveals that Akt directly regulates mTORC2. Cell Metab. 2013, 17:1009-1020.
82. Masui K., et al. mTORC2 in the center of cancer metabolic reprogramming. Trends Endocrinol. Metab. 2014, 25:364-373.
83. Kliegman J.I., et al. Chemical genetics of rapamycin-insensitive TORC2 in S. cerevisiae. Cell Rep. 2013, 5:1725-1736.
84. Chantranupong L., et al. Nutrient-sensing mechanisms across evolution. Cell 2015, 161:67-83.
85. Powis K., et al. Crystal structure of the Ego1-Ego2-Ego3 complex and its role in promoting Rag GTPase-dependent TORC1 signaling. Cell Res. 2015, 25:1043-1059.
86. Stracka D., et al. Nitrogen source activates TOR (target of rapamycin) complex 1 via glutamine and independently of Gtr/Rag proteins. J. Biol. Chem. 2014, 289:25010-25020.
87. Gaubitz C., Loewith R. Amino acid signaling in high definition. Structure 2012, 20:1993-1994.
88. Jewell J.L., et al. Metabolism. Differential regulation of mTORC1 by leucine and glutamine. Science 2015, 347:194-198.
89. Bar-Peled L., et al. Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1. Cell 2012, 150:1196-1208.
90. Wang S., et al. Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1. Science 2015, 347:188-194.
91. Rebsamen M., et al. SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1. Nature 2015, 519:477-481.
92. Jung J., et al. Amino acid-dependent mTORC1 regulation by the lysosomal membrane protein SLC38A9. Mol. Cell. Biol. 2015, 35:2479-2494.
93. Bar-Peled L., et al. A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science 2013, 340:1100-1106.
94. Tsun Z.Y., et al. The folliculin tumor suppressor is a GAP for the RagC/D GTPases that signal amino acid levels to mTORC1. Mol. Cell 2013, 52:495-505.
95. Petit C.S., et al. Recruitment of folliculin to lysosomes supports the amino acid-dependent activation of Rag GTPases. J. Cell Biol. 2013, 202:1107-1122.
96. Péli-Gulli M.P., et al. Amino acids stimulate TORC1 through Lst4-Lst7, a GTPase-activating protein complex for the Rag family GTPase Gtr2. Cell Rep. 2015, 13:1-7.
97. Yea S.S., Fruman D.A. Cell signaling, new mTOR targets Grb attention. Science 2011, 332:1270-1271.
98. Jin G., et al. Skp2-mediated RagA ubiquitination elicits a negative feedback to prevent amino-acid-dependent mTORC1 hyperactivation by recruiting GATOR1. Mol. Cell 2015, 58:989-1000.
99. Yu Y., et al. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 2011, 332:1322-1326.
100. Hsu P.P., et al. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 2011, 332:1317-1322.